Clinical Trials 下面列出了当前开展的临床试验。31 研究 Obstetrics and Gynecology (仅限开放研究). 根据地点、状态和其他条件对此研究列表进行过滤。 Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of this study is to determine the preliminary anti-tumor activity and confirm the safety of VV1 in combination with Cemiplimab. The study will concurrently enroll patients with four distinct advanced malignancies in 5 separate tumor cohorts. The four cancer types are: Non-Small Cell Lung Cancer (NSCLC) and melanoma that are progressing on checkpoint inhibitor (CPI, generally refers to anti-PD(L)1 antibodies) treatment, CPI-naïve hepatocellular carcinoma (HCC), and treatment-naïve endometrioid endometrial cancer. Pagination 临床研究 PrevPrevious Page Go to page 22 Go to page 33 Go to page 44 医疗专业人员 Obstetrics & Gynecology clinical-trials